Putting the Patient First in IBD Care: Risk Assessment and Treatment

Program Overview

The goal of this activity is to provide education about tools for assessing the risk of disease complications in patients with IBD and how to personalize treatment based on patient goals and individual disease considerations.

Credit Expired
CE Credit Expired
Expires: July 7, 2021

Target Audience

This activity is intended for gastroenterology and primary care physicians, nurse practitioners, and physician assistants who manage patients with inflammatory bowel disease (IBD).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Discuss the importance of and methods by which to perform early risk stratification for patients with IBD
  • Apply evidence-based IBD management strategies based on risk of disease complications
  • Implement individualized IBD treatment approaches based on expected benefits and risks

Activity Faculty

Corey Siegel MD

Corey A. Siegel, MD, MS

Professor of Medicine and of The Dartmouth Institute for Health Policy and Clinical Practice
Geisel School of Medicine at Dartmouth
Section Chief, Gastroenterology and Hepatology
Co-Director, IBD Center
Dartmouth-Hitchcock Medical Center
Lebanon, NH

Dubinsky2020

Marla C. Dubinsky, MD

Professor, Pediatrics and Medicine
Chief, Pediatric Gastroenterology and Nutrition
Co-Director, Susan and Leonard Feinstein IBD Clinical Center
Icahn School of Medicine
Kravis Children’s Hospital Mount Sinai
New York, NY

IRIS DOTAN PHOTO

Iris Dotan, MD

Director, Division of Gastroenterology
Rabin Medical Center
Petah Tikva, Israel
Sackler Faculty of Medicine
Tel Aviv University
Tel Aviv, Israel

Jessica Caron, MHCDS

Patient Advocate
Goffstown, NH

Supporter Statement

Provider Statement

Disclosure of Financial Relationships

Faculty

Planners and Managers

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | www.RMEI.com | (866) 770-RMEI

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources